The proportion of Pharmacy First consultations resulting in an antibiotic supply fell slightly across each of the seven clinical pathways in 2025-26, the UK Health Security Agency (UKHSA) has found.
Published last week, the UKHSA’s 2025-26 report on the English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) found that primary care accounted for 75.8 per cent of total antibiotic use, with overall consumption dropping by 7.2 per cent compared to 2024-25. General practice accounted for 65 per cent of total antibiotic consumption.
While reductions were observed in general practice and dentistry – which the report described as a return to pre-pandemic levels – antibiotic supply through Pharmacy First “increased substantially” in 2025, with a 53.1 per cent increase observed in 2025 compared to the 11 months from February 2024 to January 2025.
However, the proportion of consultations resulting in an antibiotic supply fell across each of the seven pathways by between one and five per cent, indicating that “increased activity was accompanied by proportionally lower antibiotic use” said UKHSA, adding that Pharmacy First accounted for 3.4 per cent of all antibiotics dispensed in primary care in 2025 and that phenoxymethylpenicillin and nitrofurantoin accounted for most supplies.
“The increasing use of phenoxymethylpenicillin highlights the growing role of community pharmacy in the management of sore throat and antimicrobial stewardship,” the report commented.
The UKHSA said: “Trends indicate a shift in management of the seven common conditions covered by the Pharmacy First scheme from general practice to community pharmacy, although changes should be interpreted alongside treatment access, increased public awareness of the service and changes in underlying infection rates.”
The UKHSA said a literature review on pharmacists’ role in tackling antimicrobial resistance (AMR) found that “pharmacy-led interventions were associated with reductions in inappropriate and broad-spectrum antibiotic use, increased guideline-concordant prescribing, and greater antibiotic de-escalation”.
The use of privately prescribed antibiotics declined from 2024 to 2025, which the UKHSA said was “driven mainly by reduced community pharmacy supply” and linked to increased use of Pharmacy First as well as “optimisation of antibiotic treatment durations”.
Private prescriptions accounted for 4.1 per cent of all antibiotics issued in primary care in England in 2025.